Holen Sie sich die Stockscreener-App
4.6721
0.91%
0.0421
Schlusskurs vom Vortag:
$4.63
Offen:
$4.62
24-Stunden-Volumen:
25,254
Relative Volume:
0.04
Marktkapitalisierung:
$303.39M
Einnahmen:
$207.32M
Nettoeinkommen (Verlust:
$-61.04M
KGV:
-4.8785
EPS:
-0.9577
Netto-Cashflow:
$-25.97M
1W Leistung:
-0.59%
1M Leistung:
-1.85%
6M Leistung:
+183.16%
1J Leistung:
-36.86%
1-Tages-Spanne:
$4.52
$4.715
1-Wochen-Bereich:
$4.52
$4.93
52-Wochen-Spanne:
$1.17
$7.6084
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Firmenname
Treace Medical Concepts Inc
Sektor
Branche
Telefon
(904) 373-5940
Adresse
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
4.665 | 301.11M | 207.32M | -61.04M | -25.97M | -0.9577 |
ABT
Abbott Laboratories
|
106.12 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.82 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.78 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.60 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.46 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-02-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-12-31 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-08 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-08 | Herabstufung | Truist | Buy → Hold |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2023-04-11 | Eingeleitet | Stephens | Equal-Weight |
| 2022-05-12 | Eingeleitet | BTIG Research | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten
BlackRock Inc. Takes Position in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat
Treace Medical (TMCI) Holds Gains: Stock Rises 1.09% as $4.42 Support Anchors the ChartMerger Arbitrage - vinanet.vn
Bank of America Corp DE Has $4.31 Million Stock Holdings in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts (TMCI) Gains 0.87% as Shares Approach Key Resistance at $4.87Trend Reversal Picks - siam.in
Weber Capital Management LLC ADV Invests $2.35 Million in Treace Medical Concepts, Inc. $TMCI - MarketBeat
SNDL And 2 Other Promising Penny Stocks To Watch - simplywall.st
Treace Medical (TMCI) CEO adds to stake with late‑August buys - Stock Titan
Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Acquires 39,944 Shares of Stock - MarketBeat
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Ge - The National Law Review
TMCI senior director charged with insider trading in U.S. - Peoples Gazette Nigeria
Did You Lose Money on Treace Medical Concepts, Inc. (TMCI)? Levi - The National Law Review
Treace Medical Concepts Earnings Call Signals Cautious Rebound - TipRanks
522,900 Shares in Treace Medical Concepts, Inc. $TMCI Purchased by Renaissance Technologies LLC - MarketBeat
TMCI Q2 2026 Earnings: EPS Beat Drives 6.2% Stock Uptick as Losses NarrowProfit Warning Alert - vinanet.vn
Armistice Capital (TMCI) discloses 6.36M-share Treace Medical ownership stake - Stock Titan
Treace Medical Concepts (TMCI) officer disposes shares for tax or exercise costs - Stock Titan
Treace Medical Concepts (TMCI) CEO John T. Treace reports 19.2% beneficial stake - Stock Titan
Treace Medical Concepts (TMCI) CFO uses 37,102 shares to cover equity-related taxes - Stock Titan
Treace Medical Concepts (TMCI) officer uses 16,253 shares for tax or exercise costs - Stock Titan
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50 - simplywall.st
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Analysts - marketbeat.com
Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial - MarketBeat
Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating - marketscreener.com
Treace Medical Concepts (TMCI) Stock Jumps As Cash Burn Eases But Sales Stall - Sahm
Treace Medical Concepts: Q2 Earnings Snapshot - theheraldreview.com
Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Form 8K Treace Medical Concepts Inc For: 7 August By Investing.com - Investing.com Nigeria
Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Treace Medical Concepts Inc (TMCI) (Q2 2026) Earnings Call Highlights: Revenue Declines 4% but ... - Yahoo Finance
Treace Medical Concepts, Inc. Raises Earnings Guidance for the Full-Year 2026 - marketscreener.com
Treace Medical Concepts Q2 Earnings Call Highlights - MarketBeat
Treace Medical Concepts Inc (TMCI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Treace Medical Concepts Releases Q2 2026 Financial Results - AlphaStreet
Treace Medical Concepts, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Press Release: Treace Medical Concepts Reports Second Quarter 2026 Financial Results - Moomoo
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating Challenges with Innovative Medical Solutions - DirectorsTalk Interviews
Treace Medical Concepts Inc (TMCI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Treace Medical Concepts Reports Second Quarter 2026 Financial Results - The Manila Times
Earnings To Watch: Treace Medical Concepts Inc (TMCI) Q2 2026 -- GF Value Sees 49% Upside - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Conc - The National Law Review
BlackRock, Inc. Reduces Treace Medical Concepts Inc (TMCI) Stake -- Shares Trade 30% Below GF Value - GuruFocus
Securities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) In - The National Law Review
Treace Medical Concepts, Inc. expected to post a loss of 30 cents a shareEarnings Preview - TradingView
TMCI ALERT: Levi & Korsinsky Files Securities Fraud Class Action - The National Law Review
Treace Medical Concepts (TMCI) Surges 8.6% as Buyers Target Key Resistance at $4.91Value Factor - vinanet.vn
Shareholders of Treace Medical Concepts, Inc. (TMCI): Protect You - The National Law Review
Treace Medical Concepts (TMCI) Slips 1.6% to $4.31 as Support Level Comes Into FocusNAAIM Exposure - vinanet.vn
Treace Medical Concepts (TMCI) Expected to Post Earnings on Friday - MarketBeat
BlackRock (TMCI holder) files amended 13G showing 959,320 Treace Medical shares - Stock Titan
Finanzdaten der Treace Medical Concepts Inc-Aktie (TMCI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):